Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical atorvastatin gel for prevention of radiation-induced skin toxicity in breast cancer radiotherapy
IRCT2016062219423N2Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in radiodermatitis comparing Topical atorvastatin gel with Placebo gel (2 arms). Started Sep 2016; status: completed.
02
Drugs
atorvastatin
03
Conditions
radiodermatitis
Beyond the preview
Go deeper on IRCT2016062219423N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016062219423N2.